News Releases

Bodisen Biotech Will Report Record First Quarter Earnings
Tuesday May 10, 9:30 am ET

NEW YORK--(BUSINESS WIRE)--May 10, 2005--Bodisen Biotech, Inc., (OTCBB: BBOI, website: /) announced today that it anticipates substantial growth in earnings from the production and sale of its unique organic fertilizer products for the first quarter of 2005, as compared to the corresponding period in 2004.

The completion of its state of the art manufacturing facility at the beginning of the first quarter gave Bodisen the capability to dramatically increase the orders that it was able to take from customers. Bodisen also ordered an additional three sets of new production lines, which further expanded the company's production capabilities in the first quarter.

Ms. Qiong Wang, CEO of Bodisen, commented "We are delighted with our progress in the first quarter of 2005, typically not the strongest quarter for the industry in China. The substantial increase in our production capabilities has allowed us to make up ground on the increasing demand being shown from farmers in China for organic fertilizers. We look forward to announcing results for the first quarter shortly which we anticipate will meet the high expectations of our shareholders."

Utilizing proprietary technologies, Bodisen sells over 60 packaged products in 3 product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; and Pesticides & Insecticides. Bodisen's organic fertilizers can be absorbed by plants within 48 hours while enriching soil conditions without the damaging effects associated with chemical fertilizers.

About Bodisen Biotech, Inc.

Bodisen is headquartered in Shaanxi, China, an agricultural hub of China and the economic gateway to the western regions of China. The Bodisen brand is a highly respected organic brand in China. Its "green" products support the mandate of the Chinese national government to increase crop yields for the purpose of decreasing China's dependency on food imports.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.